Current Deals

company details

THE RAMARAJU SURGICAL COTTON MILLS LIMITED

  • www.ramarajusurgical.com
  • Sector: Textile
  • CHRYSEUM SCORE: 1.50/10.00

₹223.00 0.00 (0.00%)

As on 07 Nov, 2025
L 200.00 52 Week Range H 275.00
Company Description : Ramaraju Surgical Cotton Mills Ltd, part of the Ramco Group, are the largest producer of absorbent cotton, gauze, bandages and other wound-care products in Southern India.
Company Overview
  • Name of Company THE RAMARAJU SURGICAL COTTON MILLS LIMITED
  • Sector Textile
  • ISIN INE328E01027
  • Scrip Code RAMARAJU SURGICAL
  • CIN L17111TN1939PLC002302
  • Pan No AAACT4308D
  • Face Value 10
  • Price ₹ 223.00
  • No. of Shares outstanding 0.58 Cr.
  • Market Cap 129.68 Cr
Financials
  • Revenue from operations ₹ 409.26 Cr.
  • EBITDA 7.64 Cr.
  • EBITDA Margin % 1.87%
  • Profit After Tax ₹ -29.21 Cr.
  • PAT Margin % -7.19%
  • EPS -50.23
  • Stock P/E -4.44
  • Book Value Per Share 405.37
  • P/B 0.55
  • Debt/Equity 1.84
Other Key Statistics
  • 52 week High/Low 275.00/200.00
  • Dividend Per Share 0.00
  • Dividend Yield 0.00%
  • Sales Growth - 3 years -1.80%
  • EBITDA Growth - 3 years -53.18%
  • PAT Growth - 3 years NA
  • EPS Growth - 3 years NA
  • ROE -12.39%
  • ROCE -4.75%
  • Cash Equivalents 1.16
All figures below are in INR Crores unless otherwise stated

Peer Comparison

Key Financials - FY25
Company Name Ramaraju Surgical Ambika Cotton Mills Limited Shiva Texyarn
Listing Status Unlisted Listed Listed
Revenue from Operations 409.26 702.07 322.70
Total Income 406.12 728.58 324.79
Finance Cost 38.58 16.20 11.85
Depreciation & Amortization 29.48 22.44 14.35
Total Expenses 466.54 637.39 315.06
EBITDA 7.64 129.83 35.93
PAT -29.21 65.74 12.06
No. of Shares Outstanding 0.58 0.57 1.30
EPS (in ₹) -50.23 114.93 9.30
Share Capital 5.81 5.72 12.96
Total Net Worth 235.73 904.05 135.66
Total Assets 724.75 1,151.00 304.07
Total Debt 434.41 50.72 99.50
Key Metrics:
CMP* 223.00 1,347.40 179.07
Market Cap (In Cr.) 129.68 768.02 232.79
Market Cap/Sales 0.32 1.05 0.72
EPS (Earnings Per Share) -50.23 114.93 9.30
BVPS (Book Value Per Share) 405.37 1,580.51 104.65
P/E -4.44 11.72 19.25
P/BV 0.55 0.85 1.71
EBITDA Margin 1.87% 18.49% 11.13%
ROE -12.39% 7.27% 8.89%
ROA -4.03% 5.71% 3.97%
*Market Price in ₹ as on 07 Nov, 2025

Profit Loss

FY25 FY24 FY23 FY22 FY21
Revenue from operations 409.26 365.59 407.11 432.14 282.92
Y-o-Y Revenue Growth 11.95% -10.20% -5.79% 52.74% -4.38%
Other Income 5.03 5.79 2.68 1.87 32.73
Total Income 406.12 371.38 409.79 434.01 315.65
Total Expenses (Excludes Interest and Depreciation) 398.48 348.65 375.02 359.57 242.39
Operating Profit (After deducting Depreciation) -18.70 -18.49 -9.97 26.59 23.00
OPM % -4.57 -5.06 -2.45 6.15 8.13
EBITDA 7.64 22.73 34.77 74.44 73.26
Depreciation 29.48 35.43 42.06 45.98 17.53
EBIT -21.84 -12.70 -7.29 28.46 55.73
Interest 38.58 37.57 31.59 20.77 22.00
EBT before Exceptional Items -60.42 -50.27 -38.88 7.69 33.73
Prior period/Exceptional /Extra Ordinary Items 0.00 0.00 0.00 0.00 0.00
Profit before tax/EBT -60.42 -50.27 -38.88 7.69 33.73
Tax -10.23 -7.02 -4.14 -0.73 2.06
Net Profit -29.21 -43.25 -34.74 8.42 31.67
Profit (loss) of minority interest 0.08 -5.48 -5.48 -12.73 -10.60
Total profit (loss) for period -29.29 -37.77 -29.26 21.15 42.27
EPS in Rs -50.23 -74.37 -73.46 53.63 107.00
EPS Change % -32.46% 1.25% -236.98% -49.88% 112.34%
EBITDA Change % -66.39% -34.63% -53.29% 1.61% 40.13%
Profit growth -32.46% 24.50% -512.59% -73.41% 203.06%
ROCE -4.75% -2.53% -1.48% 6.46% 13.87%
ROE -12.39% -16.27% -12.97% 2.83% 15.50%
Debt / Equity Ratio 1.84 1.69 1.58 1.09 1.00
Sales growth 3Years -1.80% 8.92%
Sales growth 5Years 6.70% 7.67%
Dividend per share 0.00 0.00

Balance Sheet

FY25 FY24 FY23 FY22 FY21
Share Capital 5.81 5.82 4.00 4.00 3.95
Reserves 227.33 259.97 263.91 293.87 268.72
Total shareholders' funds 235.73 265.79 267.91 297.87 272.67
Borrowings 434.41 450.44 422.74 325.73 273.43
Other Liabilities 15.93 19.00 17.20 24.96 16.11
Total Liabilities 489.02 487.11 459.59 375.10 312.04
Fixed Assets 248.03 278.57 297.27 241.06 244.76
Capital WIP 0.50 2.31 9.17 24.98 1.22
Investments 179.42 199.16 187.56 182.58 168.63
Other Assets 27.40 39.29 30.60 49.55 34.31
Total Assets 724.75 752.94 727.50 672.97 584.71
Cash Equivalents 1.16 40.72 3.11 9.42 3.92
Total Current liability 265.20 250.44 236.18 232.72 182.99
Total Assets -Total Current liabilty 459.55 502.50 491.32 440.25 401.72

Cash Flow

FY25 FY24 FY23 FY22 FY21
Net Cash from / (used in) Operating Activity -28.93 26.80 -5.51 47.07 39.20
Net Cash from / (used in) Investing Activity 45.19 -14.31 -67.37 -50.83 18.05
Net Cash from / (used in) Financing Activity -55.79 25.12 66.56 9.24 -55.09
Net Inc/Dec In Cash And Cash Equivalents -39.54 37.61 -6.31 5.47 2.16

Share Holding Pattern

No. of Shares in Crs. % Holding
Promoters 0.32 54.65%
Non Promoters 0.26 45.35%

News